Addressing major challenges
in antimicrobial therapies
through cutting-edge
technology and research.
Our proprietary technology is designed
to reduce bioburden and improve patient outcomes.
Creating a more human, meaningful, and healthier world for all,
through cutting edge technology and research.
About
Established in 2022, Polaroid Therapeutics is driven by a clear and ambitious mission – to create a more human and meaningful world through groundbreaking technology and research.
Our proprietary technology is carefully crafted to tackle significant challenges in antimicrobial therapies, ultimately leading to improved patient outcomes.
At Polaroid Therapeutics, we are dedicated to making a positive impact on the lives of patients and their families. Our focus is on delivering superior treatments that promote healing and enhance the overall quality of life. We are committed to reaching and assisting individuals worldwide, with the vision of touching and improving the lives of all humankind.
Our Proprietary
Technology.
Wound Management
A new era of wound care.
Our proprietary technology represents a significant advancement in antimicrobial therapies, setting a new standard in the industry. We are committed to delivering superior solutions that not only effectively addresses bioburden of resistant strains but also ensures patient safety and optimal healing outcomes.
Medical Device Coatings
Enhancing Safety
Pushing the boundaries of medical devices to ensure a safer and healthier future for patients. Infection risk is a constant concern with medical devices such as catheters and implants. By developing long-lasting coatings that effectively combat bioburden and antimicrobial resistance (AMR), we are committed to lowering the risks associated with routine and complex medical procedures.
Therapeutic Applications and Indications
A Holistic Antimicrobial Breakthrough
Embracing cutting-edge 3D printing, Artificial Intelligence, combination drugs and advanced delivery systems, our mission is to introduce groundbreaking antimicrobial treatments to the world. Through our innovative technology, we strive to deliver superior and effective treatments that can transform patient outcomes.
Meet our small
but mighty team.
Ran
Frenkel, RPh
CEO & Co-Founder
Over 25 years of expertise in pharma executive management, research & development, clinical operations, regulatory, strategy & innovation. A seasoned leader with international roles, spanning from start-ups to biotech, medical device companies, CROs, and pharmaceutical companies.
Anne
Graham
COO & CO-FOUNDER
Commercial professional with expertise in branding, communications, marketing partnerships and business development. A breadth of experience from working across varied industries including global brands, media entities, technology, entertainment, NGOs, international and domestic sports properties.
Sonia
Schmocker
Head of Regulatory and Quality Affairs
Over 14 years of experience in the MD industry, encompassing the entire lifecycle from concept to market. Expertise include leading teams through this process, articulating strategic regulatory decisions, overseeing comprehensive QMS and TD, and fostering strong communication with regulatory authorities, while ensuring effective risk management and compliance with international standards.